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The principles of quantitative structure-activity relationships (QSAR) are based on the premise
thatthe properties of a chemical are implicit in its molecular structure. Therefore, if a mechanistic
.hypothesis can be proposed linking a group of related chemicals with a particular toxic end point,
the hypo.hesis can be used to define relevant parameters to establish a QSAR. Ways in which
OSAR and in vitro toxicology can complement each other in development of alternatives to live
animal experiments are described and illustrated by examples from acute toxicological end
points. Integration of QSAR and in vitro methods is examined in the context of assessing
mechanistic competence and improving the design of in vitro assays and the development of
prediction models. The nature of biological variability is explored together with its implications for
the selection of sets of chemicals for test development, optimization, and validation. Methods are
described to support the use of data from in vivo tests that do not meet today's stringent
requirements of acceptability. Integration of QSAR and in vitro methods into strategic approaches
forthe replacement, reduction, and refinement of the use of animals is described with examples.
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Introduction
The principles of quantitative structure-
activity relationships (QSAR) are based on
the premise that the properties ofa chemi-
cal are implicit in its molecular structure.
Therefore, if a mechanistic hypothesis can
be proposed linking a group of related
chemicals with aparticular toxic end point,
the hypothesis is used to define relevant
parameters to establish a structure-activity
relationship. The resulting model is then
tested and the hypothesis and parameters
refined until an adequate model is
obtained. These principles have been suc-
cessfully applied in this laboratory to pre-
dict a skin permeability coefficients (1),
the skin corrosivity oforganic acids, bases,
phenols (2,3) and electrophilic organic
chemicals (4), and the eye irritation poten-
tial ofneutral organic chemicals (5,6).
Fora QSARto bevalid and reliable, the
dependent property for all the chemicals
covered by the relationship must be elicited
by a mechanism that is both common and
relevant to that dependent property.
Attempts to derive QSARs for data sets in
which either the dependent property is
derived by more than one mechanism or
the mechanism ofaction is wronglydefined
do notusuallylead to robustmodels.
The same principles that are applied to
the development of QSARs must also be
applied to the development of in vitro
alternatives to animal tests if those meth-
ods are to be reliable. These principles
have been overlooked in many cases, par-
ticularly in the prediction of acute toxic
effects, with inevitable results. Some alter-
native tests determine end points that are
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substantially different from those that
they claim to predict because the mecha-
nism modeled by the in vitro alternative
represents only part ofthat which is active
in vivo. In other cases, tests have been
developed that can predict end points
accurately for some classes of chemicals
but are then wrongly assumed to be
applicable to all chemical classes. The fact
that different types ofchemicals may elicit
changes in a particular biological end
point through different mechanisms clearly
has not been appreciated.
This paper describes some of the ways
in which QSARand in vitrotoxicology can
complement each other in the develop-
ment of alternatives to live animal experi-
ments by using examples from acute
toxicological end points. The mechanistic
approach to QSAR and in vitro methods is
examined in the context of assessing the
mechanistic competence, improving the
design of in vitro assays, and developing
prediction models. The nature ofbiological
variability is explored together with impli-
cations for the selection ofsets ofchemicals
for test development, optimization, and
validation. Methods are described in which
QSAR can be applied to support the use of
data from in vivo tests that do not meet
today's stringent requirements of accept-
ability. Examples are given of the integra-
tion ofQSAR into strategic approaches for
the replacement, reduction, and refinement
ofthe use ofanimals.
The MechanisticApproach
Cases in which the mechanism of action
is known or can be postulated provide
sound arguments in favor of a mechanis-
tic approach to the problem ofdesigning
alternative methods to replace animal
experiments. Based on the premise that
the properties of a chemical are implicit
in its chemical structure, ifthe mechanis-
tic basis for a specific toxicological prop-
erty of a group of related chemicals can
be elucidated and the relevant parameters
measured or calculated, then, in princi-
ple, an in vitro alternative can be estab-
lished. For an in vitro alternative to be
valid and reliable, the specific toxicologi-
cal property for all the chemicals covered
by the alternative method must be
elicited by a mechanism that is both
common and relevant to that property.
Attempts to derive in vitroalternatives for
sets ofchemicals in which either the toxi-
cological property is derived by more
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than one mechanism or the mechanism
ofaction is wrongly defined probably will
not lead to a successful outcome.
A mechanistic understanding of the
biological process underlying an in vivo
toxicity assay to be replaced, therefore,
can be expected to lead to identification
of the parameters most appropriate to
model the toxicity. The underlying scien-
tific basis ofalternative methods based on
these principles should improve their
credibility and assist their acceptance by
regulatory authorities. It could be argued
that the fact that regulatory acceptance
often is not readily forthcoming is based
partly on relatively poor understanding of
the scientific (mechanistic) basis ofmany
alternative methods.
In constructing a QSARmodel the para-
meters, where possible, should beselected on
the basis ofan understanding ofthe mecha-
nism ofthe process. When a mechanism is
not understood sufficiently to be used to
define appropriate parameters, an alternative
procedure is to compute a large number of
parameters and attempt to establish astatisti-
cal relationship with a few ofthose parame-
ters. Parameters from such a QSAR may be
useful in understanding the mechanistic
basis ofthe process. Parameters used in the
design of an in vitro model should also be
selected on the basis ofmechanistic under-
standing; selection ofappropriate parameters
can be aided byconstructing aQSARmodel
usingthesametrainingdata.
The chemicals used to construct a
QSAR or in vitro method (the training set)
should be selected on the basis of a com-
mon mechanism of action ifpossible and
should adequately cover the parameter
space in terms ofdependent and indepen-
dentvariables. It is also important to realize
that the predictive domain ofboth types of
models is restricted to the same parameter
space covered by the training set, i.e., the
model can be used forinterpolation but not
forextrapolation.
Onelimitation that mayapply to QSAR
models more than to in vitro alternatives
is that to date the successful application
of QSAR has been restricted to modeling
properties ofpure chemicals. Concerning in
vitro alternatives, it may be possible to con-
struct a complete, or mechanistically com-
petent, in vitro model and calibrate and
validate it using mixtures of chemicals. If
the constraints described above relating to
mechanisticvalidityand parameter space are
taken into account, there appears to be no
reason why such models should not provide
usefulpredictions.
Assessing Mechanistic
Competence of in VrtroTests
It has long been recognized that for a
chemical to be biologically active it first
must be transported from its site ofadminis-
tration to its site ofaction and then bind to
or react with its receptor or target (7), i.e.,
biological activity is a function ofpartition
and reactivity. If any QSAR or in vitro
model is deficient in modeling either parti-
tion or reactivity, only a partial correlation
with the in vivo response is likely to be
observed. An example is the varying degrees
ofpartial correlation with in vivodata found
with the many in vitro methods developed
and advocated as alternatives to the Draize
rabbit eye irritation test (8). Thus, it follows
that for an in vitro test to reliably predict in
vivo toxic potential, it should be sensitive to
the same parameters responsible for the
effects in vivo; such a testwould be expected
to show a high degree of correlation with
the response in vivo.
In vitro tests can be categorized as
* Empirical: those for which no mecha-
nistic basis linking the in vivo and in
vitro end points has been identified, for
example, the pollen tube growth inhibi-
tion test for eye irritants (9).
* Mechanistic: those for which the mech-
anistic link is clearly identified, for
example, in vitro photobinding to
human serum albumin test for photoal-
lergens (10).
* Analogous: those in which all or part of
the in vivosystem is reproduced in vitro,
for example, the isolated rabbit eye test
(11) and the in vitroskin corrosivity test
(12). (It is implicit that mechanisms rel-
evant to in vivo toxicity operate in an
analogous assay.)
A hypothetical example of a deficient
alternative test has been simulated (13) by
omitting a key parameter from a QSAR
model for the eye irritation potential of46
neutral organic chemicals (5). In the
original model, the parameters modeling
partition are log[octanol/water partition
coefficient], logP, a measure of hydro-
phobicity/hydrophilicity, and the minor
principal inertial axes R1 and R_ represent-
ing the cross-sectional area ofthe molecule;
the reactivity parameter is modeled by the
computeddipolemomentofeachchemical.
Figure IA is a plot of the first two
principal components of all four parame-
ters for the 46 chemicals. Except for one
chemical, the plot discriminates completely
between chemicals dassified as eye irritants
and those classified as nonirritants. In
Figure 1B, the principal components are
replotted with the dipole moment (reactivity
parameter) omitted. Although there is still
some discrimination between irritant and
nonirritant chemicals-probably because
there is a partial correlation between logP
and dipole moment-there now is one area
in the plot where irritants and nonirritants
overlap considerably. The molecular para-
meters that remain in the model are logP,
and the Ry and R, modeling partitions;
however, because dipole moment is absent,
full assessment of biologic activity cannot
be made.
Using mechanistically based QSAR
techniques has profound implications for
assessment ofthe practical utility ofin vitro
tests. Elucidating the putative mechanism of
action foradass ofchemicals facilitates eval-
uation ofan in vitro method for predicting
the in vivo toxic potential of an untested
chemical. If the QSAR is mechanistically
based, its independent variables should
define the mechanistic requirements of the
in vitroassay as well as the scope and limita-
tions of its parameter space. Therefore,
using these mechanistic requirements there
is a greater likelihood of determining (or
designing) anappropriate in vitroassay.
Chemical parameters relevant to the
mechanism ofaction must be identified for
QSAR development. Once developed, the
QSAR can be used to test the mechanistic
hypothesis developed earlier. Significant
outliers may indicate that mechanisms out-
side the existing QSAR are operating, so
new QSARs may need to be developed.
Eventually, a robust QSAR model is devel-
oped. Similarly, the process for developing
an in vitro assay should start with defining
the toxicologic phenomenon to be mod-
eled or replaced, defining relevant mecha-
nism, and categorizing chemicals on the
basis ofmechanism ofaction. An end point
in the in vitro assay should be selected on
the basis ofrelevance to the in vivotoxicity.
A second pitfall of in vitro alternatives
through whichthey mayand awayinwhich
fall short of in vivo systems they purport to
replace is the problem of multiple mecha-
nisms. As noted earlier, some alternative tests
have been developed that can predict end
points accurately for some dasses ofchemi-
cals but are often wrongly assumed to be
applicable to all chemical dasses. Chemicals
eliciting a biologic response by mechanisms
other than those covered by the scope ofthe
training setwill appear as significantoutliers.
That different types of chemicals elicit
changes in particular biologic end points
through different mechanisms often is not
arecognized. If no mechanism is identified,
Environmental Health Perspectives * Vol 106, Supplement 2 * April 1998 460OSARAND IN VITROTOXICOLOGY
024 020
0 7
0 44 0 36
80[36 71 b
7 2/
030
41 ~~~~~~~r3 /~~~[021
1 Udie 0122
mg39 0 1 190j23 0131
M14 /_ 03
a42 021 2
0129
0330
-1.0 0.0 1.0 2.0
Principal component 1
030
029
E42
* 14 8°27
*13 01 2 018
0 25
06 9 134 0132 Q132
45 *3 12 x ai19
E 16['5 3 0]4143 i
0 10 035[020 a36
0 44
* Irritan
0 Noniri
017
it
riant
3.0 4.0
0117
021
-1.0 0.0 1.0 2.0 3.0 4.0 5.0
Principal component 1
Figure 1. (A) Plot of the first two principal components of c logP, RM, and R2, and dipole moment for
chemicals showing vector loadings. Key: 1, 2-ethyl-hexan-1-ol; 2, methyl trimethyl acetate; 3, ethyl ti
n-butyl acetate; 5, ethyl acetate; 6, cellosolve acetate; 7, ethyl-2-methylacetoacetate; 8, methyl acetatE
thoughtto be an eye irritantthrough a mechanism notcovered bythis OSAR (5)1; 9, propyleneglycol; 1
propanol; 12, isobutanol; 13, n-butanol; 14, n-hexanol; 15, butyl cellosolve; 16,cyclohexanol; 17,4,4-me
butylphenol); 18, 4-bromophenetole; 19, xylene; 20, 3-chloro-4-floronitrobenzene; 21, 1,3-diisop
1-methylpropylbenzene; 23, 3-ethyltoluene; 24, 2,4-difluoronitrobenzene; 25, styrene; 26, toluene; 27, 3
2-methylpentane; 29, 1,9-decadiene; 30, dodecane; 31, 1,5-dimethylcyclooctadiene; 32, cis-cyclooct
clopentane; 34, 1,5-hexadiene; 35, methyl isobutyl ketone; 36, methyl amyl ketone; 37, methyl ethyl ki
39, allyl alcohol; 40, chloroform; 41, 2-methoxyethanol; 42, octan-l-ol; 43, dimethylformamide; 44, dir
formamide; 46, 2(2-ethoxyethoxy)ethanol. (B)Plot ofthefirst two principal components of c logP, R, al
organic chemicals showing vector loadings, i.e., dipole moment omitted. Key is identical tothatforFigi
from Chamberlain and Barratt(13)withpermission.
QSAR methods may help elucidate the
mechanisms operating in in vitro assays.
Use of QSARs to Develop
and Refine Prediction Models
Prediction models are algorithms that use
results from an alternative method to predict
toxicity observed in vivo. Aprediction model
must define the relationshi
possible results from an in
the in vivo end point, both
and quantitatively, includir
limits; it also must define th
alternative test in terms ofth
chemical properties of the
which it is valid, i.e., it m
Vector loadings
28'
c logP
physicochemical parameter space for which
it isvalid (14).
AQSARcan be regarded as aprediction
model and predictions can be made as long
as the chemical parameters responsible for
the toxicity ofthe chemical in question are
within the chemical parameter space ofthe
model (1,13).
An example in which QSAR was used
as a prediction model to construct a
Rz hypothesis that was subsequently tested is
/35° provided byWhittle et al. (15). This work
was based on a QSAR for the corrosivity
of organic acids (2), with the putative
Dipolemechanism that corrosivity is a function of
moment 6 the ability ofthe chemical to permeate the
skin together with its cytotoxicity
expressed in this case as acidity (pKj.) The
studyexamined the corrosive potential ofa
series offatty acids ranging from propanoic
acid (C3) to dodecanoic acid (C12) using
the in vitro skin corrosivity test (IVSCT)
Vectorloadings (16). In this series offatty acids, the cyto-
toxicity parameter, pKA remains constant;
clogP changes in skin corrosivity potential are
determined therefore entirely by the vari-
ables that model skin permeability-
570 log[octanol/water partition coefficient]
(logP), molecular volume, and melting
410 point (17). Because a number ofchemicals
when tested on human skin have shown
significantly different corrosivity results
than when tested on animal skin (12,18),
this series offatty acids was investigated in
200 the IVSCT using both rat skin and human
R skin. A principal components map (ex ref.
16) illustrating the corrosivity of organic
acids is shown in Figure 2. The corrosiv-
ity/irritation profile ofthe fatty acids series
toward rat skin in vitro is identical to that
46 neutral organic toward rabbit skin in vivo.
rimethyl acetate; 4, All fatty acids with alkyl chain lengths
e[methyl acetate is up to and induding C8 were found to be
1tghylycerobl;2,6dist- corrosive to ratskin. When human skin was
ropylbenzene; 22, used, the corrosive/noncorrosive threshold
-methylhexane; 28, was shifted to around the C6 fatty acid.
tene; 33, methylcy- The mechanistic interpretation of these
,etone; 38, acetone; results is consistent with the greater perme-
nethylsulfoxide; 45, ability barrier known to be associated with
indR,for46neutral human skin compared with that ofrat skin.
ure 1A. Reproduced This particular example also illustrates that
animals are not necessarily good models for
humans. The power ofthe QSAR as a pre-
p between all dictive model lies in the ability to identify
vitro test with when the rat may not be a good model for
i qualitatively humans in terms of chemical parameter
ng confidence space. Although rat skin might be useful for
e scope ofthe predicting corrosivity toward human skin
te physical and for some chemicals, there are specific chem-
substances for icals for which the rat would overpredict
ust define the the corrosive hazard for human skin.
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Figure 2. Plot of the first two principal components of logP, molecular volume, melting point, and pKa for 27
organic acids. Key: 1, dichloroacetic acid; 2, bromoacetic acid; 3, mercaptoacetic acid; 4, acrylic acid; 5, formic
acid; 6, acetic acid; 7, propanoic acid; 8, butanoic acid; 9, hexanoic acid; 10, octanoic acid; 11, decanoic acid;12,
dodecanoic acid; 13, tetradecanoic acid; 14, benzoic acid; 15, 2,4,6-trichlorophenol; 16, 2-bromobenzoic acid; 17,
4-nitrophenylacetic acid; 18, citric acid; 19, lactic acid; 20, oxalic acid; 21, salicylic acid; 22, trans-cinnamic acid;
23, cyanoacetic acid; 24, malonic acid; 25, succinic acid; 26, maleic acid; 27, sulfamic acid. Reproduced from
Whittle etal. (16)with permission.
Predictions made in parameter space
about which there is little knowledge can
be tested by conducting new experiments
in an optimum manner rather than by
incremental expansion or repeated testing
over small regions ofparameter space.
Understanding Biologic
Uncertainty
A recurring problem encountered in QSAR
models when classifying toxicologic haz-
ards is that of biologic uncertainty at
boundary regions. The concept of the
boundary region is based on the fact that
most regulatory schemes operate initially
by quantizing continuous biological (toxi-
cological) data into discrete hazard bands
that can be used conveniently in the regu-
latory process. It is the biologic variability
inherent in toxicologic testing that leads to
uncertainty in dassifying boundary regions.
One example of a boundary region is illus-
trated in Figure IA by the area marked
"c". The position of a chemical on a prin-
cipal components plot is determined solely
by its molecular features, whereas assign-
ment of a toxicity classification depends
entirely on the results from a variable bio-
logical assay, in this case the Draize rabbit
eye test. Two well-conducted Draize rab-
bit eye irritation tests on the same chemical,
for example, could lead to a nonirritant
classification for one and an irritant
classification for the other. Away from the
boundary region, the inherent biological
variability is less likely to result in two tests
leading to different dassifications.
Other examples ofsuch variability have
been cited previously. For example, tri-
ethanolamine, furfurylamine, N-methyl-
morpholine, and N-ethylmorpholine are
labeled as irritants by some suppliers and as
corrosives by others; these chemicals lie in
a region of a principal components plot for
the skin corrosivity of organic bases in
which the distinction between corrosive
and noncorrosive is unclear (3). QSAR
techniques such as principal components
analysis allow one to visualize and hence to
predict regions of chemical parameter
space in which ambiguity in in vivo results
mayarise.
Another source of variability in the
classification ofchemicals may be in regu-
latory dassification schemes. The European
Community (EC) dassification scheme for
skin irritants (19), uses two different scor-
ing systems, depending on whether the test
has been carried out using three or more
than three animals. For a three-animal test,
the classification is based on two or more
animals reaching the threshold score; when
more than three animals are tested, the
classification is based on the average score
calculated over all the animals tested. With
this scoring system a chemical with skin
O 13 irritation potential on the irritant/nonirri-
tant threshold is less likely to be classified
as a skin irritant ifit is tested on more than
O 12 three animals because it is possible for a
single animal with a low irritancy score to
reduce the average score to below the
threshold even ifthe individual scores ofall
the otheranimals are above the threshold.
Selection of Sets ofTest
ChemicalsforValidation
of in VitroTests
The performance of an in vitro test is
* Corrosive assessed by its capabilityofcorrectlypredict-
0 Noncorrosive ing the in vivoresponse. It is also reasonable
to propose that the in vitro test would not
predict the result ofan in vivo test any more
LO0 accurately than arepeat in vivotest.
There are three ways to select a set of
test chemicals to validate in vitro tests. First,
a set of chemicals could be selected for
which the biological data are either all very
high or all very low responses. Such a set of
chemicals probably would lead to a very
optimistic, although misleading, outcome
for the validation study but would do little
to test the discriminating power of the in
vitro test. Second, if the set of test chemi-
cals consisted entirely of chemicals with
uncertain in vivo data, confidence on the
in vitropredictions would at least beequally
uncertain. The third and most scientific
approach is to select a set ofchemicals for
which the in vivo responses cover the whole
range ofbiological responses-and QSAR
affords a wayofdoingthis (13).
This third method has been demon-
strated using the principal components
map for the eye irritation potential of neu-
tral organic chemicals (5). Using the prin-
cipal components map allows selection of
chemicals that cover the widest possible
parameter space in terms ofboth biological
activity and physicochemical properties.
For example, this may be achieved by
selecting a series of chemicals that would
start in an area predicted to be nonirritant,
pass through the irritant area, and move
out again into the nonirritant area. This is
illustrated by track "a" in Figure 1A. The
same principal components map can also
be used to identify regions of parameter
space incompletely covered by the current
database (e.g., in the region marked "b" in
Figure IA). Obtaining biological test data
from chemicals in these regions would be
essential for the completeness of the
nonanimal model. Similarly, the map can
be used to identify regions of parameter
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space well covered by the current database.
Testing additional chemicals in these
regions would add little valuable informa-
tion and therefore might be a waste of
valuable resources.
Similar techniques have been used in
connection with the selection oftest chem-
icals for the study sponsored on skin corro-
sivity sponsored by the European Centre
for Validation of Alternative Methods
(ECVAM) (20,21).
Availability ofGood
Quality Data
A major challenge facing researchers
developing either in vitro models or QSARs
is the sparse availability ofhigh-quality data
from experiments with animals (22).
However, where there are biological data
that do not meet today's stringent require-
ments of acceptability (see above), particu-
larly historical data generated prior to the
advent ofGood Laboratory Practices (GLP),
it is possible that QSARs may be used to
validate these data for use in alternative
tests. If QSAR techniques can be used to
demonstrate that the results ofthese tests are
consistent with the physicochemical attrib-
utes of the chemicals when compared with
the results from tests conforming to current
acceptance criteria, they can be deemed
acceptable to use for development and
validation ofin vitroalternative methods.
In a recent QSAR study of the eye
irritation potential ofneutral organic chem-
icals (6), a relationship was established
between the eye irritation data of the
European Centre for Ecotoxicology and
Toxicology of Chemicals (ECETOC) data
bank (23) (and EC classifications derived
from those data) and a large body ofhistor-
ical eye irritation data assessed by the crite-
riaofCarpenter and Smyth (24); the utility
of the latter data for use in nonanimal
alternatives is therefore increased.
Integrated Approaches
One of the strengths of QSAR is the ease
with which it can model partition either
directly, e.g., logP, or through a combina-
tion of parameters, as exemplified by the
modeling of skin permeability (1,25). On
the otherhand, one ofthe majorstrengths of
in vitro toxicology is the ease of measuring
cytotoxicity parameters, properties that
depend more on the reactivity properties of
the chemical and less on partition. Although
the reactivity parameters ofchemicals can be
calculated using chemical modeling software
or even measured directly, these methods are
often comparable onlywithin relativelysmall
areas of chemistry. A practical solution to
this problem is to use cytotoxicity data from
in vitro toxicology techniques as the inde-
pendent variables for reactivity in QSARs.
An example ofthis approach currentlyunder
development is the use ofneutral red uptake
data to measure the cytotoxicity of elec-
trophilic organic acids. These data com-
bined with parameters used in a previous
QSAR study of the corrosivity of organic
acids (2) are proving useful in discriminat-
ing between chemicals with the EC dassifi-
cations R34 (corrosive, causes burns) and
R35 (corrosive, causes severe burns) (26).
An even more important contribution
for QSAR is to play a role in integrated
strategies that lead to a reduction in the use
ofexperimental animals. Two examples of
proposed strategies are described briefly.
A scheme illustrating the strategic
approach to skin sensitization hazard iden-
tification is illustrated in Figure 3 (27). In
the first instance, a substance of defined
chemical structure to be investigated is
entered into the DEREK (deduction of
risk from existing knowledge) expert sys-
tem (28,29) to determine if it contains a
structural alert a fragment of chemical
structure that could lead to the reactivity
component of skin sensitization (30). If
no structural alert is identified, the chemi-
cal is not likely to be a significant skin sen-
sitizer; however, this should be confirmed
using a standard animal assay-the mouse
local lymph node assay (LLNA) (31) is
considered most appropriate. Ifa skin sen-
sitization structural alert is identified, the
chemical has met the first ofthe two criteria
forclassification.
To be classified as a skin sensitizer, a
chemical must be able not only to react
chemically with skin protein either directly
or after appropriate metabolism but also to
partition into the relevant skin compart-
ment. Skin permeability is assessed using a
QSAR model (1). Ifthe skin penetration of
the chemical is sufficiently high, the chemi-
cal is assumed also to have significant skin
sensitization potential and can be classified
and labeled accordingly. Ifskin penetration
is judged to be insignificant, the chemical is
considered unlikely to be a skin sensitizer.
In the latter case and where the extent of
skin penetration is judged to be moderate
or equivocal, it is considered advisable to
assess the chemical with a suitable animal
model. Again, the LLNA is considered the
most appropriate test method.
Regardless what triggers the decision to
conduct an LLNA, the practical outcome is
the same. If the chemical is positive in this
(No label
Figure 3. A strategic approach to skin sensitization
hazard identification. Reproduced from Basketter et al.
(27) with permission.
assay, it should be classified a skin sensi-
tizer and labeled accordingly (32). When
the result clearly does not meet the crite-
ria for classification, then in our view no
further work should be necessary. The
chemical may be regarded as having insuf-
ficient sensitization potential to merit
classification and labeling as a skin sensi-
tizer. This proposed strategy provides an
important opportunity for both substan-
tial reduction and refinement of animal
usage in a manner that does not compro-
mise the existing standards of classifica-
tion and labeling ofskin sensitization hazard
in the European Union
The second strategy for identifying and
classifying chemicals causing skin irritation
or corrosivity uses a combination ofQSAR
and in vitromethods (33). In cases in which
the chemicals are predicted confidently to
be noncorrosive and ethical approval can be
obtained, the final stage in the strategy is a
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human 4-hr patch test. A practical example
of the use of this strategy has already been
provided in "Use ofQSARS to Develop and
Refine Prediction Models."
Conclusions
A number of ways to integrate QSAR
knowledge and in vitro method develop-
ment and evaluation have been explored. A
major limitation is the mechanistic under-
standing of many toxicological phenom-
ena. Where such understanding does not
already exist, we have shown how develop-
ment of QSARs may help elucidate and
clarify such mechanisms of action. This
approach requires careful and systematic
consideration of toxic effects, especially
reexamining the descriptors ofin vivo toxi-
city. With the current state ofknowledge,
the simpler toxicities, such as eye and skin
irritation and skin sensitization, are more
amenable to QSAR analysis. There already
are indications, however, that more com-
plex toxicities, for example a2p-globulin
nephropathy (34), peroxisome prolifera-
tion (35), and teratogenicity (36), may be
similarlyamenable to these approaches.
Ultimately, QSAR models have the
potential to be used reliably to predict toxi-
city ofchemicals and thus replace animals
in some toxicity studies. In the meantime,
QSARmethods can be used to
* evaluate the mechanistic competence of
in vitromethods
* refine existing in vitro methods and give
insight into the design ofnewones
* reduce the need for testing and hence
reduce the numberofanimals used
* provide balanced selections ofchemicals
for use in thevalidation ofin vitrotests
* check the acceptability and consistency
ofbiological data for use in the develop-
ment and validation of alternative
methods
* play a role in integrated strategies along
with both in vitro and in vivo tests and
eventually lead to a reduction in the use
ofexperimental animals.
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